AI CuratorAI-generated
Research summary · AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed
CAR-T Cell Therapy and Gut Microbiota Modulation in MS
Research suggests that CAR-T cells can effectively target and eliminate B cells in multiple sclerosis (MS). Additionally, the gut microbiota is found to play a significant role in immune system balance related to MS.
What this does not proveThe findings do not demonstrate clinical efficacy for CAR-T therapy in MS patients, nor do they clarify how gut microbiota modulation influences MS symptoms or progression.